artificial intelligence (AI)

The Kingdom’s digital health market is projected to reach US$11.07 billion by 2033, highlighting growing demand for advanced healthcare technologies.

Through the expanded partnership, Mayo Clinic will clinically integrate Exer AI’s hand and wrist module into its orthopaedic workflows to support musculoskeletal care.

The AI-powered guidance will focus on building sustainable habits related to diet, physical activity, recovery and sleep, helping individuals make informed lifestyle decisions in real time.

The partnerships will enable healthcare providers to integrate wearable and out-of-hospital monitoring technologies into the Philips ecosystem.

The team chemically synthesised nearly 300 of the AI-generated genomes and tested them in laboratory conditions, with sixteen of the resulting viruses proving viable.

The companies will combine Evotec’s screening technologies, compound libraries and AI-enabled discovery platform with Odyssey’s expertise in the biology of autoimmune and inflammatory diseases.

The initiative supports Abu Dhabi’s broader strategy to use digital health technologies, real-world evidence and artificial intelligence to advance preventive and personalised healthcare.

Novo Nordisk will also use H1’s technology to support several aspects of clinical research, including trial design, patient enrollment and clinical trial site selection.

The company has launched Invenia Automated Breast Ultrasound (ABUS) Prime and ABUS StreamVue, which target different stages of the breast imaging workflow.

DeepHealth Breast Ultrasound automates several stages of breast ultrasound examinations, including lesion detection, characterisation and reporting.